Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Krugerrand 1/2 oz 1,693.00 - CHF per 1/2 Ounce 1/2/26 11:00 AM Popular Articles Copyright © 2025 Insider Inc and finanzen.net GmbH (Imprint). All rights reserved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback